Intelligent OMICS

How Arctoris’ platform Ulysses helped validate promising AI-derived lung cancer targets.

More Case Studies / Testimonials:

Validation of a Simulation-Derived Novel Drug Target in Oncology

Developing a Robust, Reliable and Sensitive Antibody Detection Assay

Profiling AI-driven JAK Inhibitors for COVID-19 Treatment

Validation of Novel Drug Targets for Neurodegenerative Diseases

Arctoris succeeds in generating difficult to express functional proteins.

Arctoris successfully reproduces data from literature across 4 biophysics assays.

Arctoris produces high quality protein for crystallization and resolves the structure of KRAS

Arctoris resolves the structure of VRK1 bound to inhibitors and determines dissociation constants.